- Home
- MLYS vs CYH Comparison
MLYS vs CYH Comparison
Compare MLYS & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLYS | CYH |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 432.2M |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MLYS | CYH |
|---|---|---|
| Price | $23.90 | $2.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | ★ $48.67 | $3.57 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 03-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.43 | ★ 196.67 |
| EPS | N/A | ★ 3.77 |
| Revenue | N/A | ★ $12,485,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.17 |
| P/E Ratio | ★ N/A | $0.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.44 | $2.24 |
| 52 Week High | $47.65 | $4.43 |
Technical Indicators
Market Signals| Indicator | MLYS | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 30.24 | 33.20 |
| Support Level | $13.42 | $2.41 |
| Resistance Level | $31.09 | $3.25 |
| Average True Range (ATR) | 1.76 | 0.16 |
| MACD | -0.30 | -0.06 |
| Stochastic Oscillator | 11.34 | 9.55 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.